Targeting of MCL-1 in breast cancer-associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
Thomas L. Bonneaud(Centre National de la Recherche Scientifique), Frédérique Souazé(Centre National de la Recherche Scientifique)
Cited by 20
Related Papers
Low BCL-xL expression in triple-negative breast cancer cells favors chemotherapy efficacy, and this effect is limited by cancer-associated fibroblasts
|Scientific Reports|2024|15
Targeting of MCL-1 in breast cancer associated fibroblasts reverses their myofibroblastic phenotype and pro-invasive properties
|bioRxiv (Cold Spring Harbor Laboratory)|2021|1
Cancer associated fibroblasts mitigate the efficacy of the combination of chemotherapy and BCL-xL targeting in triple negative breast cancer cells
|bioRxiv (Cold Spring Harbor Laboratory)|2023|1